{"version":"1.0","provider_name":"Clario","provider_url":"https:\/\/clario.com","author_name":"Gary Norman","author_url":"https:\/\/clario.com\/author\/garyn\/","title":"Suicide risk assessment in clinical trial drug development: part 1","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"ye8VBYqY71\"><a href=\"https:\/\/clario.com\/resources\/articles\/suicide-risk-assessment-in-clinical-trial-drug-development-part-1\/\">Suicide risk assessment in clinical trial drug development: part 1<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/clario.com\/resources\/articles\/suicide-risk-assessment-in-clinical-trial-drug-development-part-1\/embed\/#?secret=ye8VBYqY71\" width=\"600\" height=\"338\" title=\"&#8220;Suicide risk assessment in clinical trial drug development: part 1&#8221; &#8212; Clario\" data-secret=\"ye8VBYqY71\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n<\/script>\n","description":"Accurately assessing suicidal ideation and behavior (SIB) is critical and often required by the Food and Drug Administration (FDA) in clinical trials designed to assess the safety and efficacy of new pharmaceuticals.","thumbnail_url":"https:\/\/clario.com\/wp-content\/uploads\/2021\/09\/Kelly-Posner-headshot.png"}